Uncategorized

7/26/2011 – Medical marijuana legislation is nothing new to New York or Connecticut. A serious push was seen in Hartford earlier this year and Albany has considered bills for over a decade. Despite considerable public support and a growing choir of patient voices, neither state has passed a law. Now, statements from New Jersey’s conservative Governor Chris Christie have elected officials in NY and CT looking at their future cannabis options.

Rhode Island, Maine and Vermont  have working medical cannabis programs and even some open dispensaries. But Gov. Christie was a federal prosecutor for seven years prior to being elected governor. During a July 19th press conference about medical marijuana he offered an insightful discussion of the various “intersections” between state and federal laws.

It is important to note that NY and CT are considering very narrow and limited bills, modeled after New Jersey.

The Hartford Advocate reported on 7/25

A bill to legalize medical marijuana in Connecticut kind of withered away in the 2011 General Assembly, never reaching a vote in the state House or Senate. The bill’s supporters say the intense focus on state budget problems and concerns about how to grow and regulate medical pot created roadblocks for a bill similar to one that passed and was vetoed by Republican Gov. M. Jodi Rell several years ago.

Gov. Dannel Malloy supports legalizing medical marijuana in Connecticut. His top criminal justice adviser, Michael Lawlor, says he expects new legislation modeled on the systems in New Jersey, Rhode Island and similar programs in other states will pass the legislature in 2012.

Lawlor says it’s very unlikely the new bill will be anything like the freewheeling medical pot program in California. “They’re selling pot brownies in the shop windows out there,” says Lawlor. read full

New York Governor Andrew Cuomo made a slight shift in his medical cannabis position. Because he was so staunchly against the issue, his comments are notable.  On 7/25 the Elmira Star-Gazette reported:

Cuomo, a Democrat, has not supported medical marijuana in the past, and he said he has not changed his position. He did, however, leave the door open on the issue.

“We have proponents of the policy. I know New Jersey’s looking at it. We have opponents of the policy,” he said. “We’re talking to both sides of the issue, if you will, and we’re reviewing it, but we don’t have a final position.”

The governor said that while he hadn’t changed his stance, “We’re always learning and listening and talking and growing, we hope.”

New Jersey became the 16th state to legalize medical marijuana under legislation signed by Christie’s predecessor.

Legislation to allow patients with debilitating illnesses to use marijuana if they are registered with the state and receive a prescription from their physician has passed the Assembly before but never the Senate. Under the bill, sponsored by Assemblyman Richard Gottfried and Sen. Thomas Duane, both Manhattan Democrats, hospitals and pharmacies would do the bulk of the dispensing. The maximum amount that could be dispensed would be 2.5 ounces. read full

Actually NJ was the 14th state to pass a medical marijuana law when legislation was signed in 2010;  Arizona and Delaware were #15 and #16.

Will these heavily restrictive schemes for marijuana actually work for seriously ill patients? That remains to be seen.

What is more certain is that regulated medical cannabis growing in the Garden State – with the blessing of a former US Attorney – could have a significant influence on New York and Connecticut.

John Wilson (left) and Jim Miller in New Jersey

1/26/2012 – Living with multiple sclerosis has never been easy for John Ray Wilson. It will get even tougher tomorrow when he goes to jail. Like thousands of MS patients around the country John found that marijuana helped relieve his condition. But without healthcare and unable to afford medical quality cannabis on the streets Wilson grew seventeen marijuana plants behind his Franklin Township home in 2008.

Every resource in the State of New Jersey has been thrown at John from helicopters to aggressive prosecutors. This week the NJ Supreme Court refused to hear his final appeal. So at 8:30AM on 1/27  John will surrender himself at the Somerset County Courthouse to serve the remainder of his 5-year prison sentence.

This afternoon John was at home with his family, putting his affairs in order and preparing for a dinner out with friends. He was convicted just before the New Jersey medical marijuana law was passed in 2010.

“I’ve almost given up hope. I mean it’s been 2 years and there’s no patients even registered yet,” Wilson lamented.

The medical marijuana program, administered by the Department of Health and Senior Services (DHSS), has struggled under heavy regulations.

“When I do finally get out,” Wilson asks, allowing only the smallest hope in his voice, “can I have my medicine?”

Not only is the NJ marijuana program still on paper but those in prison cannot access the state-legal medicinal cannabis at all. Those on probation or parole may have a difficult time as well. Drug testing is often standard practice. Qualifying residents, even those with conditions like AIDS or MS, might still get into trouble for being a registered medical marijuana patient and testing positive for THC.

“John Ray Wilson exemplifies the fact the NJ has some of the most retroactive, ill-advised draconian marijuana laws in the country,” said civil rights attorney William Buckman who represented Wilson in the appeal.

“The notion that taxpayers should pay to lock up a sick man for 5 years is ludicrous and tragic,” said Buckman,”The governor should quickly commute his sentence.”

Governor Chris Christie could intervene. State Senator Raymond Lesniak issued a press release yesterday also renewing that call:

“I am disappointed by the recent decision of the Supreme Court to deny the appeal of John Ray Wilson. Mr. Wilson was not selling drugs on our streets. He was merely trying to alleviate the symptoms of a dreadfully painful and regressive disease. It is unconscionable that this Friday he will be behind bars.

“Three years ago, I called on Governor Corzine to commute the sentence of Mr. Wilson. After inaction with the last governor, I was hopeful Governor Christie would better understand the unfair reality of this situation. Unfortunately, Governor Christie has been just like Governor Corzine, refusing to use his and only his power to make things right when the true intentions of the law were misapplied.”

Wilson’s family, fellow patients and medical marijuana advocates plan to rally at the Somerset County Courthouse as John arrives on Friday morning.

The Coalition for Medical Marijuana New Jersey (CMMNJ) has been keeping up demonstrations in support of John since his original trial. The group plans to hold solidarity events for Wilson while he is in prison.

John Wilson’s case has symbolized the ongoing plight of New Jersey’s medical cannabis patients.

CMMNJ – http://www.cmmnj.org

Support John Ray Wilson on Facebook – https://www.facebook.com/pages/Support-John-Ray-Wilson-New-Jersey-MS-Patient/104540271138

CALL or TWEET to Governor Chris Christie 609-292-6000 or @GovChristie – ask him to “Pardon medical marijuana patient John Ray Wilson!”

Chris Goldstein is a respected marijuana reform advocate. As a writer and radio broadcaster he has been covering cannabis news for over a decade. Questions?  [email protected]

Sandy Fiaola, NJ multiple sclerosis patient

July, 20, 2011 press release from The Coalition for Medical Marijuana New Jersey (CMMNJ) www.cmmnj.org

Gov. Christie Allows Medical Marijuana, Regulations Still Need Work

Trenton – NJ Governor Chris Christie held a press conference on July 19, 2011 to address the status of the Compassionate Use Medical Marijuana Act. He has decided to reverse his suspension of the program and allow six Alternative Treatment Centers to move ahead with their operations.

After discussing the various intersections or conflicts between state and federal laws Christie said, “I have instructed the Commissioner of Health to move forward as expeditiously as possible to implement the [program].”

VIDEO: http://www.livestream.com/governorchrischristie/video?clipId=pla_a1a6bf2e-1630-4282-bb87-f28f93e72f9a&utm_source=lslibrary&utm_medium=ui-thumb

“We are happy that the governor is moving forward with the medicinal marijuana program,” said Ken Wolski, a registered nurse and executive director of the Coalition for Medical Marijuana New Jersey (CMMNJ). “Patients have suffered too long waiting for this,” said Wolski, “In thousands of cases patients in NJ have already died without the improvement in quality of life and relief of suffering that marijuana can bring.”

CMMNJ remains focused on a final set of rules for the program that will be workable. “We still have a number of concerns about the regulations put out by the DHSS for this program,” Wolski said, “The physician registry is unnecessary and will disqualify numerous patients.  Plus the cap on THC level is arbitrary and home delivery is not being permitted. These are all roadblocks to patient access that we hope the Christie Administration will reconsider.”

Some of the ATCs have expressed the same concerns. http://newyork.cbslocal.com/2011/03/07/nj-to-hold-hearing-on-medical-marijuana-rules/

Seriously ill New Jersey residents who would qualify under the law expressed surprise and measured hope at the governor’s change in rhetoric.

Jay Lassiter lives with HIV and has testified for better regulations in Trenton, “This is a small step in the right direction for New Jersey and I’m glad that Governor Christie has finally discovered a sense of urgency to help New Jersey residents with cancer and AIDS. I look forward to the day when I won’t be a criminal just for taking medical cannabis.”

Charles Kwiatkowski, a father of three, lives with multiple sclerosis and has been one of the most visible patient advocates in New Jersey. “It’s good and bad…all the restrictions,” Kwiatkowski said today. “But, I’ll believe it when I see it. So far it has been a really long, painful wait.”

[Editor’s Note – Freedomisgreen posts submitted content to the site. If you are interested in sending press releases, text or photos please contact [email protected] .]

Read more at Freedomisgreen.com

Executives from the mainstream pharmaceutical industry, savvy cannabis experts who already run a facility in Montana and a powerful political figure are the people behind Compassionate Sciences Inc. They are one of the first six non-profit businesses who will operate a medical marijuana center in New Jersey. Like most of the other approved facilities they plan intense investments into the research side of their business.

The application states: “Our mission at Compassionate Sciences is to establish a facility and product that meets a pharma-standard of palliative care.” But the details of their operation to achieve those goals were not released.

The group had the most heavily redacted application for the medical cannabis Alternative Treatment Centers. The NJ Department of Health and Senior Services released over 130 of the 184 pages blank. Missing were financial details and information on the physical location of the site. While the rest of the facilities give a specific address or at least a town, Compassionate Sciences Inc. just lists Burlington or Camden Counties as their targeted areas to build.

What DHSS did release were the resume-style biographies for the key players. So let’s meet some of the first people who will be able to legally grow, sell and research marijuana in the Garden State.

Compassionate Sciences ATC Senior Management Team

Richard Taney, Chief Executive Officer.
Mr. Taney is a chief executive with extensive experience in health care, medical technology and financial services. Mr.Taney assumed leadership of Compassionate Sciences after serving as CEO of Delcath Systems, Inc., (NASDAQ: DCTH), a medical technology company that developed a patented system for the targeted delivery of ultra-high dose chemotherapy to the liver for treatment of a variety of cancers. Under his leadership, Delcath Systems achieved widespread adoption by doctors and hospitals. Mr. Taney is also a Trustee of the Compassionate Sciences ATC.

Jack Burkholder, Chief Financial Officer.
Mr. Burkholder is a consultant with more than 30 years of experience in international investment banking, corporate finance and real estate development. He has an expertise in managing complex projects involving close cooperation with governments at all levels and has served extensively in the public trust as a court-appointed receiver. Mr. Burkholder is active in his community as a member of the Real Estate Roundtable and the audit committee of his local school district. He graduated with a BS in Agriculture from Cornell University. Mr. Burkholder is also a Trustee of the Compassionate Sciences ATC.

Michael Nelson, Chief Operating Officer.
Mr. Nelson is the founder of a highly successful international outfitting business who is also the owner and operator of one of the largest and most respected ATC’s in Montana. As a grower-operator over the last six years, he has developed experience in the building of ATCs, systems design,ATC employee orientation and training and management. Mr. Nelson’s cultivation center and multiple-location dispensaries have set a standard of excellence in serving qualified patients throughout the Central and Western regions of the State. Mr.Nelson brings to his work a background in sales, management, distribution and marketing of school products to universities and high schools across the American Northwest. He is active in the Bozeman area business community and as a volunteer in a sports program for the disabled. Mr. Nelson earned a BS in Business from the University of Colorado.

Nicole Wagner, Master Grower.
Ms.Wagner is an accomplished government and academic analyst and researcher in the fields of sustainable agriculture, ecology, agronomy, statistics, engineering and economics. With an expertise in global and domestic agricultural policy, she has served as an international economist and crop assessment analyst at the U.S. Department of Agriculture as well as a researcher at Montana State University. Ms. Wagner has published numerous research studies and has a deep understanding of diversified agricultural systems including organic vegetable and dairy production, conventional corn, soybean, and small grains production. She is also a director of the non-profit Community Food Alliance and works with Field Day Farms, a Community Supported Agriculture (CSA) farm that supports 30 families. Ms. Wagner earned her PhD. in Land Resources and Environmental Sciences from Montana State University and attended the University of Minnesota where she earned her Masters and BA in Biosystems and Agricultural Engineering. She developed her expertise as head grower at the Mr. Nelson’s medical Cannabis facility in Montana.

Andrei Bogolubov, EVP of External Affairs.
Mr. Bogolubov is a communications professional who has served government, major multinationals, regional and emerging growth companies in a wide range of industries around the world. His expertise is in public affairs, business development and community outreach. Mr.Bogolubov’s healthcare, medical and pharmaceutical clients have included American Home Products, Bristol Myers Squibb, Columbia Presbyterian Hospital, Medical Excellence, The Michael J. Fox Foundation, Pfizer, Pharmacia & Upjohn and Value Options. He also has served in government as Assistant to the Secretary for Public Affairs at the US Department of the Interior where he was also the Department’s public affairs liaison to the White House. Mr. Bogolubov developed his expertise in community relations as Director of Policy & Communications at a major national grassroots citizens lobby. Mr. Bogolubov began his public sector career on the committee staff of the Connecticut State Legislature and later served as an aide to a US Congressman.

Noel Palmer, Chemist (consultant).
Dr Noel Palmer is a respected chemist with an expertise in plant and soil chemistry. He is skilled in chromatographic and spectroscopy methods, specializing in the detection of heavy metals, pesticides, and herbicides in both soil and plant matter. He received his doctorate in analytical and soil chemistry from the University of Idaho. The focus of Dr. Palmer’s work was applying various analytical methods to look at soil systems and humic materials and their interactions with various inorganic compounds. Earlier, he managed a soil research lab at the University of Idaho. Dr. Palmer brought his skill in performing chromatographic separations to the analysis and study of Cannabis chemistry. He is a member of the board of the Alliance for Cannabis Science, an international community of Cannabis scientists. Dr Palmer is also the lab manager for Montana Botanical Analysis, a research lab in Montana focused on the study of Cannabis chemistry. His research has been published in more than 10 peer-reviewed scientific papers.

Compassionate Sciences Trustees

Webster B. Todd, Jr.
Mr. Todd brings to Compassionate Sciences experience, judgment and insight he developed over the course of a distinguished career in government, politics and commercial aviation. As a public servant, he was a member of the White House staff and the New Jersey General Assembly as well as a State Department official and the Chairman of the National Transportation Safety Board. Among his private sector achievements, Mr. Todd was the founder of Princeton Aviation Corp, Senior Director of Air Safety at the Airline Pilots Association and President of Frontier Airlines. Throughout his career, Mr. Todd has been active in the community including service as a Director of the New Jersey Commerce and Economic Growth Commission, a member of the Tewksbury Township Agricultural Advisory Board and as a New Jersey firefighter.

Dr. Steven Patierno.
Dr. Patierno is a leader in the science and medicine of cancer who is Executive Director of the George Washington University Cancer Institute. He also serves as Vivian Gill Distinguished Professor of Oncology, GW School of Medicine; Professor of Pharmacology & Physiology, Genetics & Urology, The GW School of Public Health & Health Services; Health Sciences Professor of Environmental & Occupational Health; and Founding Director of the Molecular &Cellular Oncology Program. Dr. Patierno has over two decades of experience managing over $30 million of grants including large, complex biomedical research grants (both laboratory and population sciences), as well as community-based grants in cancer disparities, prevention and control, education and outreach, and survivorship. Dr. Patierno is also an accomplished teacher who was been the recipient of the GW Medical Student’s Golden Apple Award. He is the principal mentor to 20 Ph.D. graduate students and Program Director to over 50 graduate students as well as 20postdoctoral fellows, medical residents and undergraduate trainees. Dr. Patierno earned his PhD in pharmacology at the Graduate School of Biomedical Science at University of Texas Health Science Center in Houston and the MD Anderson Cancer Institute where he was awarded the prestigious Rosalie B. Hite Graduate Fellowship in Cancer Research for his work on the genetics of cancer causation.

All six of the approved ATC applications, redacted by NJ DHSS, have been posted online here for public review:  http://www.scribd.com/NJcannabisDocs

MS patient Charles Kwiatkowski – photo by C. David Freitag

7/25/2011 – Praise continues this week for NJ Governor Chris Christie’s decision to follow the compassionate use law and the state constitution, ending another delay for the medical cannabis program. Six Alternative Treatment Centers (ATCs) will now move forward with operations. But the type of system being attempted is an entirely new animal and the regulations have not been finalized.

Shunning the holistic approach to therapeutic marijuana, the Christie Administration has sanctioned a centralized “medical model” with severe limitations compared to other states. The result of this narrow scope may not be exactly what patients had in mind when they envisioned access.

Medical cannabis in the Garden State will not be served from glass cases that house nine strains of Indica buds or from shelves of carefully frosted cupcakes and brownies. Instead it will likely be served over a counter that looks exactly like a pharmacy in pill bottles full of homogenized, ground-up plant matter.

There are two levels of unique restrictions, first is the compassionate law itself: New Jersey legislators allowed the shortest list of qualifying medical conditions in the country, a monthly supply of just two ounces and cut out home cultivation. Last minute language also limited cannabis products to lozenges, topical creams and raw material.

The proposed rules from the Christie Administration are the next level. They created the nation’s first mandatory cannabis doctor registry, capped THC content at 10 percent and would stop the six ATCs from home delivery or growing more than three strains. Those are just the highlights.

The full regulations, over 100 pages of them, are so bad that they could hamstring the program. The executive suspension/un-suspension has overshadowed this important part of the process.

Patients have spent the last year testifying against the rules before committees at the Senate, Assembly and even the Department of Health and Human Services (DHSS). Physicians and potential ATC operators (even some of the winners) also criticized the worst of the new restrictions.

Hearing those concerns, the Legislature passed new resolutions with bi-partisan support. Stating that the regulations violated the true intent of the compassionate use law elected officials began a rare process to invalidate them.

The winning ATC proposals already conform to the draconian rules. The ATCs are led by political players from both parties teamed up with hand-picked executives from top-tier medical and pharmaceutical institutions. Big names drip from the resumes: Pfizer, Rutgers University, The Robert Wood Johnson Foundation, George Washington University Cancer Center, The National Transportation Safety Board.

The New Jersey ATCs are the best funded, most politically connected medical marijuana operations in America. Most of the NJ ATCs plan to spend tens of millions of dollars researching the plant and its component cannabinoids. Qualifying patients are not considered customers but are treated more like doctor-ordered participants in some sort of advanced medical experiment.

But even the ATCs want the limitations lifted on THC potency and plant variations. Right now DHSS could change the rules voluntarily or the Legislature could continue in their resolve to force a re-write. Presumably, some action must be taken in order for the ATCs to proceed as expeditiously as Gov. Christie is now directing.

October 15, 2012 – The NJ Department of Health (DOH) announced today that final permits were in place for the first medical marijuana dispensary: Greenleaf Compassion Center in Montclair, NJ. These are called “Alternative Treatment Centers (ATCs)” under the severely restrictive regulations.

Greenleaf ATC effectively enjoys a monopoly on all of the legal cannabis cultivation and distribution in a state of almost 9 million residents.  One of the five ATCs is just getting started in Egg Harbor Township while the other four are not even close to opening. More than a year after gaining the initial contract three of the NJ marijuana ATCs have not even secured a location.

NJ DOH reports that about 190 patients have completed the registration process. The unique restrictions in New Jersey prevents DOH from sending out ID cards directly to the patients. Instead, all of the NJ medical marijuana ID cards will be shipped to Greenleaf Compassion Center for the patients to pick up, in person. CORRECTION – Update 10/19/12 – Some patients have received ID cards via UPS. We are waiting for more information from NJ DOH.

No announcement has been made yet from the management at Greenleaf as to when they actually plan to open their doors. In media appearances this summer Greenleaf reported that they were already growing cannabis at an undisclosed NJ location.

When Greenleaf won one of the six ATC contracts, freedomisgreen.com pointed out that they were very well connected. Former Montclair Mayor Jerry Freed personally went to bat for their application. NJ Assemblyman Thomas Giblin (Deputy Majority Leader for the Democrats) sits on their medical board.

New Jersey’s medical marijuana program is the most limited in the country.  It is the only state that requires physicians to join a special list to recommend cannabis. So far only 175 doctors are available in the program, most in northern NJ.

NJ ATCs can only provide patients with two ounces of marijuana per month. ATCs can only grow three strains of cannabis at a time; all must have less than 10% THC potency. The only forms of cannabis an ATC can sell patients are: raw plant material, lozenges and a topical cream.

New Jersey’s harsh regulations mean that the vast majority of qualifying residents will likely remain in the underground cannabis market. Without obtaining one of the extremely difficult to obtain ID cards, these seriously ill residents will be left without legal protections if they are caught by police.

Chris Goldstein is a respected marijuana reform advocate. As a writer and radio broadcaster he has been covering cannabis news for over a decade. Questions?  [email protected]

NJ Gov Christie denies stalling but admits rewriting medical marijuana law

9/2/2011 – Several news sources offered conflicting reports that one of New Jersey’s first Alternative Treatment Centers for cannabis was going to start building a facility.

Fox29 in Philadelphia declared:

The Garden State’s first medical marijuana growing center is on its way to Chesterfield Township, Burlington County. Read full

But the local Burlington County Times found out that the plans were not so firm:

Representatives from a West Trenton-based alternative treatment center have informed officials that they’re scouting locations in the township for a growing facility, but have not named a specific location nor submitted a site plan application to the Planning Board.

Compassionate Care Foundation Inc. canceled plans to appear before the Township Committee several weeks ago and has not communicated since, said Mayor Larry Durr, acknowledging the many unanswered questions about the plan. Read full

Chesterfield is a rural, farming community near McGuire Air Force Base.

Gov. Christie’s administration removed plans for home delivery of medical marijuana. Unless that restriction is lifted, patients or a designated caregiver must go to an ATC to pick up medicine.

This isn’t the first time that Compassionate Care Foundation has run into location issues. In March the company had announced plans to build in Bellmawr, NJ. That was apparently shocking news the mayor and local officials, who eventually turned away the ATC.

Having a relationship with the local community was supposed to be an important part of the scoring process for the NJ ATC applicants.

A prominent member of Compassionate Care Foundation’s Board of Trustees, David Knowlton, was an acting Commissioner of the state Department of Health and Senior Services.  NJ DHSS is the oversight entity for the medical marijuana program. Knowlton was also a member of Chris Christie’s gubernatorial transition team.

In fact, three of the six ATCs have very close ties back to Governor Christie, who has stated many times that he does not like the safe access law.

Gov. Christie suspended the operations at all of the ATCs for several months. Then, at a widely covered press conference on July 19th, Christie promised that state-regulated cannabis would be available to patients by December 2011.

In order to reach that goal the ATCs would need to start growing in the next eight weeks. As of this writing, none of the six ATCs have confirmed a physical location.

One ATC, Greenleaf Compassion Center, has plans to build in Montclair, NJ. On the surface they seem to have the most local support. Former mayor Jerry Fried, Montclair State University and some sitting city council members have all backed the concept. Still, an actual location for Greenleaf has not been announced.

The New Jersey Compassionate Use Medical Marijuana Act was signed into law in January 2010. Since that time the underground cannabis market and secretive, personal cultivation remain the only points of access for NJ residents with qualifying medical conditions.

Chris Goldstein is a respected marijuana reform advocate. As a writer and radio broadcaster he has been covering cannabis news for over a decade. Questions?  [email protected]

6/8/2011 – There are nine state-approved medical cannabis facilities prepared to open on the east coast. They have veritable dream-teams of expert staffers and some have tens of millions of dollars ready to invest. But Rhode Island Gov. Lincoln Chafee and New Jersey Gov. Chris Christie are holding them back.

The six in NJ and three in RI have already been approved by state authorities after a tough bidding process. On paper, they are the most heavily regulated and carefully vetted marijuana centers in the country.  But a perceived threat of federal law has given pause to the two governors.

“We received what I consider to be a clear communication that the current compassion center program would be a violation of federal law,” said Claire Richards Chief Legal Officer for RI Gov. Chaffee.

Richards is referring to a letter from US Attorney Peter Neronha that was hand-delivered in April.  Days later, Chafee announced a hold on issuing the Certificates of Registration to the dispensaries.

New Jersey has received no communication from any federal official about medical marijuana. Not to be left out, NJ Attorney General Paula Dow has sent two letters requesting clarification from the Department of Justice on April 22nd and May 23rd. But there has been no reply.

Governor Christie and his policy office have stated that NJ will not move forward until a federal clarification has been issued. New Jersey has no provisions for home cultivation by patients; they are forced into the central system of Alternative Treatment Centers. So far, not a single patient has been registered.

Freedomisgreen.com spoke via telephone with potential facility operators in RI and NJ.  Neither would go on record with details but both expressed frustration at the current situation. Each took time to re-affirm their commitment to endure the process and eventually go into operation.

Rhode Island Rep. Scott Slater took several local patients to meet with Governor Chafee on June2nd – the same day US attorney General Eric Holder was in Providence for an unrelated visit.  Holder was cornered by the media who were asking nothing but cannabis questions. The Providence Journal reported Holder’s seemingly off-the-cuff statement:

“We are in the process of working these issues with the U.S. attorney for Rhode Island and other U.S. attorneys across the country,” he said.”My hope is that something in the not too distant future …. will be addressed.” read full

The quote sent hopeful waves through the medical cannabis community around the country. But was it enough to lift the hold on RI dispensaries? Nope.

“We were heartened to hear it,” said Claire Richards at Gov. Chaffee’s office. “Right now we are still waiting to see what he will say.”

The Garden State also seems content to wait for the federal Godot.  Messages left today at the press office for the NJ Department of Health and Senior Services inquiring about the status of the program went unanswered. Presumably the NJ hold also remains in effect.

It remains unclear as to why the two states are waiting for a federal blessing to proceed. The compassionate use measures were debated for several years in their respective legislatures. Elected officials were fully aware of the inherent conflict with federal policy when they passed the laws. But it may take unprecedented tolerance from the USDOJ in order to get these nine medical cannabis centers off of paper and into practice.

Chris Goldstein is a respected marijuana reform advocate. As a writer and radio broadcaster he has been covering cannabis news for over a decade. Questions?  [email protected]